Literature DB >> 21810972

Another piece of the puzzle: is there a "nodal" monoclonal B-cell lymphocytosis?

Paolo Ghia.   

Abstract

Mesh：

Year:  2011        PMID： 21810972      PMCID： PMC3148900          DOI： 10.3324/haematol.2011.047712

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  19 in total

1.  Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly.

Authors:  Paolo Ghia; Giuseppina Prato; Cristina Scielzo; Stefania Stella; Massimo Geuna; Giuseppe Guida; Federico Caligaris-Cappio
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

Review 2.  Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management.

Authors:  T D Shanafelt; P Ghia; M C Lanasa; O Landgren; A C Rawstron
Journal:  Leukemia       Date:  2010-01-21       Impact factor: 11.528

Review 3.  CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it?

Authors:  Lydia Scarfò; Antonis Dagklis; Cristina Scielzo; Claudia Fazi; Paolo Ghia
Journal:  Semin Cancer Biol       Date:  2010-09-15       Impact factor: 15.707

4.  Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells.

Authors:  U Klein; Y Tu; G A Stolovitzky; M Mattioli; G Cattoretti; H Husson; A Freedman; G Inghirami; L Cro; L Baldini; A Neri; A Califano; R Dalla-Favera
Journal:  J Exp Med       Date:  2001-12-03       Impact factor: 14.307

Review 5.  Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL).

Authors:  Andy C Rawstron; Tait Shanafelt; Mark C Lanasa; Ola Landgren; Curtis Hanson; Alberto Orfao; Peter Hillmen; Paolo Ghia
Journal:  Cytometry B Clin Cytom       Date:  2010       Impact factor: 3.058

6.  Monoclonal B cell lymphocytosis in hepatitis C virus infected individuals.

Authors:  Claudia Fazi; Antonis Dagklis; Francesca Cottini; Lydia Scarfò; Maria Teresa Sabrina Bertilaccio; Renato Finazzi; Massimo Memoli; Paolo Ghia
Journal:  Cytometry B Clin Cytom       Date:  2010       Impact factor: 3.058

7.  Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis.

Authors:  Sarah E Gibson; Steven H Swerdlow; Judith A Ferry; Urvashi Surti; Paola Dal Cin; Nancy Lee Harris; Robert P Hasserjian
Journal:  Haematologica       Date:  2011-05-05       Impact factor: 9.941

Review 8.  The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.

Authors:  Elias Campo; Steven H Swerdlow; Nancy L Harris; Stefano Pileri; Harald Stein; Elaine S Jaffe
Journal:  Blood       Date:  2011-02-07       Impact factor: 22.113

9.  Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts.

Authors:  Andy C Rawstron; Michael J Green; Anita Kuzmicki; Ben Kennedy; James A L Fenton; Paul A S Evans; Sheila J M O'Connor; Stephen J Richards; Gareth J Morgan; Andrew S Jack; Peter Hillmen
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

10.  Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis.

Authors:  M C Lanasa; S D Allgood; A D Volkheimer; J P Gockerman; J F Whitesides; B K Goodman; J O Moore; J B Weinberg; M C Levesque
Journal:  Leukemia       Date:  2009-10-15       Impact factor: 11.528
View more
  2 in total

1.  Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden.

Authors:  Falko Fend; José Cabecadas; Philippe Gaulard; Elaine S Jaffe; Philip Kluin; Isinsu Kuzu; Loann Peterson; Andrew Wotherspoon; Christer Sundström
Journal:  J Hematop       Date:  2012-09       Impact factor: 0.196

Review 2.  [In situ lymphoma and other early stage malignant non-Hodgkin lymphomas].

Authors:  L Quintanilla-Martínez; P Adam; F Fend
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.